Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
KEY PRODUCTS
Reset all filters
01 1Fareva
Reset all filters
01 1DEFEROXAMINE MESYLATE USP
Reset all filters
01 1Luxembourg
Reset all filters
01 1Active
Reset all filters
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-06-25
Pay. Date : 2013-01-15
DMF Number : 25421
Submission : 2012-03-01
Status : Active
Type : II
20
Excella Gmbh And Co Kg, based in Luxembourg, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Fareva: One stop for innovative drug development, precision manufacturing and high-quality APIs.
One of their notable products is DEFEROXAMINE MESYLATE USP, with a corresponding US DMF Number 25421.
Remarkably, this DMF maintains an Active status since its submission on March 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 25, 2013, and payment made on January 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II